• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Biochem Biophys . The importance of accessory protein variants in the pathogenicity of SARS-CoV-2

tetano

Editor, Senior Moderator
Arch Biochem Biophys


. 2022 Jan 24;109124.
doi: 10.1016/j.abb.2022.109124. Online ahead of print.
The importance of accessory protein variants in the pathogenicity of SARS-CoV-2


Sk Sarif Hassan[SUP] 1 [/SUP], Pabitra Pal Choudhury[SUP] 2 [/SUP], Guy W Dayhoff 2nd[SUP] 3 [/SUP], Alaa A A Aljabali[SUP] 4 [/SUP], Bruce D Uhal[SUP] 5 [/SUP], Kenneth Lundstrom[SUP] 6 [/SUP], Nima Rezaei[SUP] 7 [/SUP], Damiano Pizzol[SUP] 8 [/SUP], Parise Adadi[SUP] 9 [/SUP], Amos Lal[SUP] 10 [/SUP], Antonio Soares[SUP] 11 [/SUP], Tarek Mohamed Abd El-Aziz[SUP] 12 [/SUP], Adam M Brufsky[SUP] 13 [/SUP], Gajendra Kumar Azad[SUP] 14 [/SUP], Samendra P Sherchan[SUP] 15 [/SUP], Wagner Baetas-da-Cruz[SUP] 16 [/SUP], Kazuo Takayama[SUP] 17 [/SUP], Ãngel Serrano-Aroca[SUP] 18 [/SUP], Gaurav Chauhan[SUP] 19 [/SUP], Giorgio Palu[SUP] 20 [/SUP], Yogendra Kumar Mishra[SUP] 21 [/SUP], Debmalya Barh[SUP] 22 [/SUP], Raner Jośe Santana Silva[SUP] 23 [/SUP], Bruno Silva Andrade[SUP] 24 [/SUP], Vasco Azevedo[SUP] 25 [/SUP], Aristóteles Góes-Neto[SUP] 26 [/SUP], Nicolas G Bazan[SUP] 27 [/SUP], Elrashdy M Redwan[SUP] 28 [/SUP], Murtaza Tambuwala[SUP] 29 [/SUP], Vladimir N Uversky[SUP] 30 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS- CoV-2) with an estimated fatality rate of less than 1%. The SARS-CoV-2 accessory proteins ORF3a, ORF6, ORF7a, ORF7b, ORF8, and ORF10 possess putative functions to manipulate host immune mechanisms. These involve interferons, which appear as a consensus function, immune signaling receptor NLRP3 (NLR family pyrin domain-containing 3) inflammasome, and inflammatory cytokines such as interleukin 1β (IL-1β) and are critical in COVID-19 pathology. Outspread variations of each of the six accessory proteins were observed across six continents of all complete SARS-CoV-2 proteomes based on the data reported before November 2020. A decreasing order of percentage of unique variations in the accessory proteins was determined as ORF3a > ORF8 > ORF7a > ORF6 > ORF10 > ORF7b across all continents. The highest and lowest unique variations of ORF3a were observed in South America and Oceania, respectively. These findings suggest that the wide variations in accessory proteins seem to affect the pathogenicity of SARS-CoV-2.

Keywords: ORF10; ORF3a; ORF6; ORF7a; ORF7b; ORF8; Pathogenicity; SARS-CoV-2.
 
Back
Top Bottom